Unpredictability of Intravenous Busulfan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation for Advanced Beta Thalassemia: Limited Toxicity with a Dose-Adjustment Policy-Reference-Cited by-同舟云学术

Unpredictability of Intravenous Busulfan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation for Advanced Beta Thalassemia: Limited Toxicity with a Dose-Adjustment Policy

Published:2010-05 Issue:5 Volume:16 Page:622-628
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Chiesa Robert,Cappelli Barbara,Crocchiolo Roberto,Frugnoli Ilaria,Biral Erika,Noè Anna,Evangelio Costanza,Fossati Marco,Roccia Tito,Biffi Alessandra,Finizio Valentina,Aiuti Alessandro,Broglia Monica,Bartoli Antonella,Ciceri Fabio,Roncarolo Maria Grazia,Marktel Sarah

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. Global epidemiology of haemoglobin disorders and derived service indicators;Modell;Bull World Health Organ,2008

2. Survival and complications in thalassemia;Borgna-Pignatti;Ann NY Acad Sci,2005

3. Allogeneic stem cell transplantation for thalassemia major;Angelucci;Haematologica,2008

4. Advances in the allogeneic transplantation for thalassemia;Lucarelli;Blood Rev,2008

5. Graft rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics;Slattery;Bone Marrow Transplant,1995

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemoglobinopathies (Sickle Cell Disease and Thalassemia);The EBMT Handbook;2024

2. Busulfan and cyclophosphamide‐based conditioning regimen still holds the promise of being a safe and efficacious regimen for allogeneic transplantation in patients with transfusion‐dependent thalassemia, even in high risk;European Journal of Haematology;2022-07-26

3. Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review;Journal of Clinical Medicine;2022-02-09

4. Therapeutic drug monitoring of intravenous busulfan in Thai children undergoing hematopoietic stem cell transplantation: A pilot study;Pediatric Hematology and Oncology;2021-03-03

5. Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma;Therapeutic Advances in Hematology;2021-01